
AI vs. Daffodils: Crafting a Cheaper Alzheimer’s Drug
Galantamine treats Alzheimer’s. Artificial intelligence and biosensors may pave the way to make this drug faster and cheaper.

Galantamine treats Alzheimer’s. Artificial intelligence and biosensors may pave the way to make this drug faster and cheaper.

A long, long time ago (1930), brains were smaller. Are today’s bigger brains connected to improvements in rates of dementia?

Trontinemab is a very exciting experimental drug, showing great promise in rapidly clearing Alzheimer’s amyloid plaques from the brains of affected individuals, with remarkably little side effects.

The first 3D-printed brain tissue that can grow and function like typical brain tissue is a major breakthrough for scientists in search of an Alzheimer’s cure.

Walk through the various steps that occur as a person participates in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) project.

Researchers found the walls of the brain’s small arteries are also affected in Alzheimer’s, reducing blood flow. Learn about this new treatment target.

Find out how two biomarkers in saliva diagnose pain in dementia, effectively and non-invasively.

VIDEO+ARTICLE: Kenneth S. Kosik traced an Alzheimer’s gene mutation to a 16th century founder. See him solve this puzzle of the past and show why this can help the future.

Lecanemab, the newest Alzheimer’s drug, is getting a boost by focusing ultrasound waves on the blood-brain barrier. Learn more about this next step in delivering better Alzheimer’s treatments.

“It is exciting to see efficacy of potential new drugs for Dementia with Lewy Bodies, the most common dementia after Alzheimer’s. It is a huge area of unmet need,” said Dr. Marwan Sabbagh.

DEMENTIA GIFT IDEAS: People with Alzheimer’s may lose abilities, but feelings still matter. What once wasn’t much of a gift, may now be a great one. What were nice presents may no longer be right. See these thoughtful suggestions.

Alzheimer’s treatment eligibility may be far larger than previously thought. A major Nature study using blood tests suggests millions more older adults could qualify for treatment than current use reflects. As diagnosis becomes easier, demand for drugs like Leqembi could shift sharply.

Israel pairs the developed world’s highest birth rate with the lowest crude dementia prevalence in a major European comparison—an advantage rooted in demographics that gives the country valuable time to prepare better for caregivers and families.

It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.

What are the early symptoms of Alzheimer’s? When to get a professional evaluation.

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
No spam, only news and updates.


